Clinical Trials Directory

Trials / Completed

CompletedNCT02062658

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.

Conditions

Interventions

TypeNameDescription
DRUGKetamine0.5mg/kg IV
BEHAVIORALExposure and Response PreventionA type of Cognitive Behavioral Therapy called Exposure and Response Prevention.

Timeline

Start date
2013-12-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-02-14
Last updated
2016-12-29
Results posted
2016-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02062658. Inclusion in this directory is not an endorsement.

Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) (NCT02062658) · Clinical Trials Directory